BioCentury
ARTICLE | Finance

Home sweet krone

Why Swedish rare disease play Wilson Therapeutics stayed local with its IPO

May 23, 2016 7:00 AM UTC

Wilson Therapeutics AB (SSE:WTX) opted to list locally in Stockholm and secured enough cash to ignore the markets until 2020, which is when it plans to hire a sales force for its rare disease asset.

On May 12, Wilson raised SEK383.3 million ($46.5 million) in a bumped-up IPO of 8.5 million shares at SEK49. The deal valued Wilson at SEK1.2 billion ($150.7 million)...